|
|
||||||||||
Research Articles |
We report a case of hypervagotonia manifested by idioventricular rhythm in a healthy, athletic man who participated in a Phase I study of an investigational calcium-channel blocker. Upon breaking the study's double-blind study code, it was discovered that the subject had received placebo. We discuss this unusual finding and the implications of including athletic subjects in safety/tolerance studies.
This article has been cited by other articles:
![]() |
A. J. Barsky, R. Saintfort, M. P. Rogers, and J. F. Borus Nonspecific Medication Side Effects and the Nocebo Phenomenon JAMA, February 6, 2002; 287(5): 622 - 627. [Abstract] [Full Text] [PDF] |
||||